A catalytically active fragment of the Rap-speci®c guanine-nucleotide exchange factor C3G was expressed in E coli. It was puri®ed and its interaction with GTPbinding proteins was investigated using¯uorescence spectroscopy. C3G stimulates GDP dissociation from Rap1, but not from Rap2, neither from Bud1, which is believed to be the yeast homologue of Rap1 nor from all other proteins of the human Ras-subfamily. Like the corresponding fragment from CDC25 Mm , the increase in the GDP dissociation rate is linear with increasing concentration of Rap1A . GDP up to 100 mM, indicating an apparent K M higher than 100 mM. Unlike the Ras-CDC25
Introduction
The members of the superfamily of Ras-related GTPbinding proteins cycle between an inactive GDP-bound and an active GTP-bound state. They become activated when a guanine-nucleotide exchange factor (GEF) accelerates the slow intrinsic dissociation rate of protein-bound GDP, which allows GTP in the cell to bind (Bourne et al., 1990) . Return to the inactive state is achieved by the GTPase reaction which is usually very slow but becomes accelerated by a GTPaseactivating protein (GAP). Most of these regulatory GEFs and GAPs are speci®c for each protein of the dierent Ras-subfamilies (Boguski et al., 1993) .
Ras and Rap, with several isoforms N-, K-and HRas; Rap1A and B, Rap2A and B, belong to the Ras subfamily of the superfamily of Ras-related GTPbinding proteins. While Ras is a major regulator of cell growth, the function of Rap proteins is unclear. To date several Ras-speci®c exchange factors have been identi®ed: CDC25
Mm or Ras-GRF, SOS1 and SOS2 (reviewed in Boguski et al., 1993) , but until recently no speci®c exchange factor for Rap was known. A Rapspeci®c exchange factor, called C3G, was identi®ed in a screen for SH3 domain-binding proteins of the adapter protein Crk (Tanaka et al., 1994; Knudsen et al., 1994) and was found to contain the CDC25 homology boxes. Initially, it was thought to be another ras-speci®c GEF since C3G could complement the CDC25 de®ciency of S. cerevisiae (Tanaka et al., 1994) . However, when the protein was puri®ed from Sf9 cells it was shown to be much more active on Rap1 than on Ras and thus should be considered a Rap-speci®c GEF (Gotoh et al., 1995) .
Ras and Rap1 contain the same core eector region (residues 32 ± 40) Pizon et al., 1988) and bind to the same set of eectors molecules such as Raf kinase and Ral-GEF (Wittinghofer and Hermann, 1995) . This, together with the observation that Rap1, when overexpressed, can reverse the K-Ras transformed phenotype of NIH3T3 cells , has led to the hypothesis that Rap1 could be a possible antagonist of Ras. Several studies indeed showed this antagonistic action of Rap1 on a variety of Ras-dependent responses and possibly also in the sevenless signal transduction pathway (for references see Bokoch, 1993; Noda, 1993) . Despite this, a reversal of the transformed phenotype in a variety of human tumor cell lines upon expression of Rap1A was not observed (Sato et al., 1994) . The biological relevance of this putative Ras-antagonistic eect of Rap1 is therefore still unclear. It is even more confusing that Rap1 has also been described to act similar to Ras by stimulating DNA synthesis in Swiss 3T3 cells (Yoshida et al., 1992) and activating B-Raf in a cell free system (Ohtsuka et al., 1996) . In addition, Ras-independent actions of Rap have been reported, such as the regulation of platelet aggregation (Altschuler et al., 1995; Franke et al., 1997) and the oxidative burst (Maly et al., 1994; Gabig et al., 1995) . Thus, although Rap1 is now known to aect multiple processes, a clear picture of its biological function still needs to be elucidated. Despite the 70% homology between Rap1 and Rap2 proteins (Bokoch, 1993) , Rap2 proteins cannot antagonize Ras (JimeÂ nez et al., 1991) and, except for an eect on mottling in X. oocytes (Carnero et al., 1995) , their function is unknown.
An important tool in elucidating the biological function of a particular GTP-binding protein is the use of dominant negative mutants, of which S17-mutants are the most commonly used (Stacey et al., 1991; Medema et al., 1991; Nobes and Hall, 1995) . Ras(S17N) was found in a random screen for weak binding mutants of Ras and was shown to bind GDP more tightly than GTP (Feig and Cooper, 1988; Farnsworth and Feig, 1991) . Ras(S17N) inhibits the activation of wild-type Ras by GEF and it has been postulated that this is due to the tighter binding of GEF to the mutant (Powers et al., 1989; Stacey et al., 1991; Farnsworth and Feig, 1991) .
In this paper, we investigaged the enzymatic properties and speci®city of the catalytic domain of C3G, the Rap-speci®c exchange factor. In addition we analysed whether the putative dominant negative mutant Rap1A(S17N) could inhibit the interaction of C3G with wild-type Rap1A.
Results and discussion
In a ®rst attempt to obtain the catalytic domain of C3G, a similar construct (residues 775 ± 1078 in pGEX4T2) to the one described by Gotoh et al. (1995) was made. However, in our hands, this GSTfusion protein was highly insoluble (Figure 1 ) and did not show any guanine nucleotide exchange activity towards Rap1A. This insolubility is most likely due to the expression in E. coli since Gotoh et al. expressed this GST-fused fragment of C3G in COS7 cells. For CDC25
Mm
, we could de®ne a minimal domain of 248 residues, which can be expressed in E. coli and retains full guanine nucleotide exchange activity towards Ras (RH Cool, to be published elsewhere). By aligning the sequence of C3G with that of CDC25
Mm we identi®ed a similar fragment of 249 residues (amino acids 830 ± 1078) in the C3G sequence. This fragment was then expressed in E. coli and puri®ed as a GST-fusion protein on glutathione sepharose, cleaved with thrombin and isolated. The protein was at least 80% pure and was recognized by anti-C3G antibodies (Figure 1 ).
Fluorescent analogues of guanine nucleotides have ®rst been applied to study the biochemistry of Ras (Eccleston et al., 1988; John et al., 1988) and it has been shown that on binding to Ras the¯uorescence emission of mGDP increases approximately twofold when it binds to the protein (John et al., 1988) . The same result was obtained for Rap . mGDP (not shown). We than used this¯uorescent analogue to study the interaction of Rap proteins with C3G. Figure 2 shows the slow time-dependent¯uorescence change at 450 nm, when Rap1B . mGDP is incubated in the presence of 100-fold excess of unlabeled GDP, representing the intrinsic GDP dissociation rate. Upon addition of C3G-CD, the nucleotide is released more rapidly. The rate is dependent on the concentration of GEF. We found that C3G-CD is twice as active on Rap1A compared to Rap1B (Table 1 ). To further de®ne the speci®city of C3G we tested its GEF activity towards Rap2 and all Ras proteins. Surprisingly, in spite of the 70% homology of Rap1 and Rap2 (Bokoch, 1993) , C3G-CD does not react with Rap2A (Table 1 ) and only very weakly with Rap2B ( Figure 3 ; Table 1 ). A similar discrimination in favour of Rap1 over Rap2 has been reported for two dierent RapGAPs (Rubin®eld et al., 1991; Wienecke et al., 1995) . These ®ndings suggest that Rap2 proteins most likely have their own regulatory proteins and their identification might help elucidating the biological function of Rap2. We con®rm the results of Gotoh et al. (1995) that C3G does not stimulate the guanine nucleotide dissociation from H-and N-Ras ( Figure 3 ; Table 1 ), but we now extend this ®nding to K-Ras (Table 1) , Rras (3.6-fold stimulation by 1 mM C3G-CD) and TC21 (4.0-fold stimulation by 1 mM C3G-CD). Bud1 (Rsr1) is believed to be the yeast S. cerevisiae homologue of Rap1 (Bender and Pringle, 1989) and shares some functional homology with Rap1 (McCabe et al., 1992) . Its GTPase is stimulated in vitro by the mammalian Rap-speci®c GTPase-Activating Protein (Holden et al., 1991; McCabe et al., 1992) . A similar functional overlap was expected for the Rap-GEF, as C3G was found to complement the CDC25 defect in S. cerevisiae (Tanaka et al., 1994) . However, as shown in Table 1 , C3G-CD hardly recognizes Bud1 . mGDP.
Since dominant negative eects of the S17N mutant of Rap1 have not been described, we wondered whether Rap1A(S17N) is able to bind to C3G and inhibits its action. We prepared the mutant and compared its biochemical properties to that of HRas(S17N). As for Ras (Feig and Cooper, 1988) and for Rap2A the dissociation rate constant of GDP from the mutant is much faster (&50-fold) as that of wild-type Rap (Table 1 and Figure 1 Puri®cation of C3G. Bacteria expressing the GST-fused catalytic domain of C3G were sonicated and the pellet and supernatant fractions after centrifugation for 10 min at 13 000 g were analysed by SDS ± PAGE, followed by immunoblotting using C3G-speci®c antibodies. Lanes 1 and 2: GST-C3G-CD (construct aa 775 ± 1078), pellet and supernatant, respectively. Lanes 3 and 4: GST-C3G-CD minimal domain (aa 830 ± 1078), pellet and supernatant, respectively. Only the minimal domain of C3G-CD was soluble and active. Protein preparations of the catalytic domain were more than 80% pure as determined by SDS ± PAGE followed by Coomassie blue staining: C3G-CD after thrombin cleavage (lane 5). crude extract (lane 6) Figure 4 ). We have shown that H-Ras(S17A) has a weaker anity to both GDP and GTP and that this is almost exclusively due to a dierence in the dissociation rate (John et al., 1993) . On the basis of the very similar eect of Rap1A(S17N) on nucleotide dissociation, we assume that its anity for GDP is similarly reduced. We next tested whether the dissociation of GDP from the mutant can be further stimulated by C3G-CD. Figure 4 shows that Rap1A(S17N) is able to interact with C3G-CD (& ®vefold stimulation by 1 mM C3G-CD, see also Table 1 ). The H-Ras(S17N) mutant has been postulated to inhibit the interaction between wild-type Ras and the GEF as a consequence of its tighter binding to the GEF in comparison to wild-type Ras (Powers et al., 1989; Stacey et al., 1991; Farnsworth and Feig, 1991) . We therefore assayed the ability of Rap1A(S17N) to inhibit the action of C3G on wildtype Rap1A. To our surprise, even the addition of 5 mM Rap1A(S17N) did not inhibit the GEF activity ( Figure 5a ). Under comparable conditions HRas(S17N) almost completely inhibits the CDC25 Mm catalyzed dissociation of mGDP from Ras ( Figure 5b ). Addition of 10 mM S17N-Rap1A only very slightly inhibited the interaction of C3G-CD with wild-type Rap1A (not shown). Thus even though the S17N mutation has a similar eect on the nucleotide dissociation rate of Rap1A and H-Ras, this seems not sucient for inhibition. In the case of Ras(S17N) (RH Cool, to be published) and most likely also the yeast homolog Ras2(G22A) (Haney and Broach, 1994), a signi®cant decrease in the apparent K M of the reaction is found compared to wild-type. We therefore measured the Michaelis Menten constants by taking catalytic amounts of C3G-CD (50 nM) and increasing amounts of either wild-type Rap1A . mGDP or Rap1A (S17N) . mGDP. As shown in Figure 6 , both reactions are linearly dependent on the substrate concentration up to 100 mM, when saturation was still not reached, indicating that the K M of both reactions is likely to be higher than 100 mM. These data suggest that the anity of C3G for the GDP-bound mutant is similar to that for wild-type. The lack of inhibition of the GEF-stimulated mGDP release from wild-type Rap1A in vitro, together with a similar K M value compared to wild-type Rap1A, suggests that (S17N)Rap1A is unlikely to act as a dominant negative mutant in vivo by titrating away C3G. Although our data cannot exclude the possibility that (S17N)Rap1A will sequester full-length C3G but not the catalytic domain of C3G, we consider this unlikely as a similar construct of CDC25 Mm could be sequestered by (S17N)Ras. So far, most studies with Rap have focused on its possible antagonistic eects on Ras and therefore activating mutants rather than dominant negative mutants have been used. In those studies in which S17 mutants of Rap1A has been examined, this mutant was found to be inactive (S17D in ref. Kitayama et al., 1990 ; S17N in refs. Maly et al., 1994 and Gabig et al., 1995) , as predicted from the observed decrease in nucleotide anity, in analogy to the Ras situation. To our knowledge, only two reports have proposed a dominant negative eect of Rap1A(S17N) and this is most likely not due to sequestration of its GEF, as activating mutants as well as the`dominant negative' mutant of Rap1A were both found to inhibit the activation of the NADPH oxidase complex (Maly et al., 1994; Gabig et al., 1995) . However, after Figure  4 Interaction of C3G with Rap1A(S17N). Rap1A(S17N) . mGDP was incubated with 100-fold excess unlabeled GDP alone or with increasing concentrations of C3G-CD as indicated . mGDP in the presence or absence of the indicated concentrations of C3G-CD after addition of 100-fold excess of unlabeled GDP. The assay was performed at 258C in 50 mM Tris, pH, 7.5, 5 mM MgCl 2 and 5 mM DTE submitting our manuscript, Vossler et al. (1997) described a dominant negative eect of (S17N)Rap1A on the cAMP-dependent activation of Elk-1. This seems to be in contrast to our data, but one explanation could be the very large amount of (S17N)Rap1B (10 mg of DNA) that was used to transfect PC12 cells as we do observe some inhibition using 10 mM (S17N)Rap1A in our in vitro assay. For inhibition of the Ras pathway much smaller amounts of Ras(S17N) are normally used. More likely however, the dominant negative eect of (S17N)Rap1B observed by Vossler et al. is caused by titration of another not yet identi®ed Rap-GEF, since C3G could not potentiate the cAMP-mediated activation of ERKs (Vossler et al., 1997) . In another very recent paper, C3G and Rap1 were also found to be on separate pathways (Tanaka et al., 1997) .
Conclusions
It has always been treated as a dogma that the mutation of Ser/Thr analogous to Ser-17 of Ras makes the protein a dominant negative version of the respective GTP-binding protein, thus making this mutant very useful for studying the biological pathways of the respective protein under investigation. Here we have shown that the C3G-dependent activation of Rap1A is not inhibited by Rap1A(S17N), although the mutation seems to reduce the nucleotide anity to a similar extent as in Ras. This suggests that Rap1A(S17N) will most likely not act as a dominant negative mutation which sequesters the Rap1-speci®c exchange factor C3G. It also stresses the importance of studying the Rap1-GEF interaction for the purpose of developing a dominant negative inhibitor for the Rap1-speci®c GEF and thereby create a tool to study the biological function of Rap1, which is still a mystery at the present time.
Materials and methods

GTP-binding proteins
C-terminally truncated Rap1A (residues 1 ± 167) was prepared from ptacRap1A and puri®ed by a two-column puri®cation procedure similar to that of Ras (Tucker et al., 1986) as described before (Herrmann et al., 1996) . The S17N mutation was introduced into ptacRap1A (residues 1 ± 171) using the megaprimer PCR method (Picard et al., Mm -CD is severely inhibited by H-Ras(S17N) . GDP Figure 6 Apparent Km measurements. 50 nM C3G-CD was incubated with increasing concentrations of Rap1A . mGDP (a) or Rap1A(S17N) . mGDP (b) and the decrease of¯uorescence in the presence of 200-fold excess of unlabeled GDP was measured with time. At Rap concentrations 4200 nM, the substrate was a mixture of 200 nM Rap . mGDP and increasing concentrations of Rap . GDP. The observed initial rates, in pmols/s, were determined graphically and plotted against the concentration of Rap1A . (m)GDP. The volume was 1200 ml 1994) and the mutagenesis primer 5'-GTTGGGAG-GAATGCATTGACAGTTCAG-3' (codon for Asn17 underlined). Full-length Rap1B, starting from a cDNA clone kindly given to us by Dr Hans Bos, was expressed from the E. coli expressed vector ptac such that the translation initiation site is the same as that for Ras (Tucker et al., 1986) and Rap1A: GAATTCTATG, with the EcoRI restriction site and translation initiation codon underlined. It is puri®ed by the same procedure as for Rap1A. The expression vectors for full length Rap2A (ptac) and Rap2B (pGEX) were kindly donated by Dr Jean de Gunzburg. GST-Rap2B was puri®ed from the bacterial extract by GSH-sepharose, cleaved with thrombin and puri®ed as non-fusion protein by standard procedures. ptac-Rap2A was puri®ed similarly to ptac-Rap1A. Full length H-ras, K-ras, N-ras and R-ras were puri®ed as described before (Tucker et al., 1986; Herrmann et al., 1996) . The R-ras clone was kindly provided by Dr Alan Hall. Full length TC21 (in pGEX, a gift of Dr Channing Der) was puri®ed as a GST-fusion protein and cleaved with thrombin by standard procedures and was then further puri®ed on a Q-sepharose column. C-terminally truncated Bud1 (residues 1 ± 251) ampli®ed from genomic yeast DNA and cloned into the pET11a vector was provided by Dr Reza Ahmadian. The protein was puri®ed by a two-column procedure: Q-sepharose chromatography was followed by loading the run-through on a SP-sepharose column.
Expression and puri®cation of a catalytic fragment of C3G
The clone for full-length human C3G (Tanaka et al., 1994) was a kind gift of Dr Michiyuki Matsuda. The catalytic domain was ampli®ed by PCR with the forward 5' -CATGGATCCGCAGCCAGGCCGGGGACCTTGC AC-3', (C3G coding residues for amino acids 830 ± 837 underlined) and reverse primer 3'-TTTTGTCTGGCCC TTCTCTTCTGGATCATTGAGCTCCAGCTGATATA-5' (C3G coding residues for amino acids 1070 ± 1078, underlined) creating a BamHI site at the 5'-and an XhoI ± SalI site at the 3'-terminal end. The resulting PCR fragment was inserted into the BamHI ± SalI sites of pGEX4T2 to create pGEX-C3G-CD (CD=catalytic domain). In analogy to CDC25 Mm /Ras (RHC, to be published elsewhere) we tried to stabilize the GEF fragment by co-expressing it with Rap1A (1 ± 167). In short, the complete expression cassette of Rap1A in ptacRap1A (1156 bp EarI fragment) was cloned into the NotI site of the pGEX-C3G-CD by blunt end ligation. Surprisingly, we found no expression of Rap1A from this co-expression vector under the conditions used to express soluble GST-C3G-CD proteins (induction started at OD600=1.2 with 0.05 mM IPTG and further incubation overnight at 208C). This incorporation of Rap1A in pGEX4T2 did not in¯uence the expression, puri®cation and activity of GST-C3G-CD. The bacterial pellet was solubilized in PBS+10% glycerol+10 mM DTE+5 mM EDTA+150 mM (NH 4 ) 2 SO 4 +100 mM Pefablock SC (Merck) and stored at 7808C. GST-C3G-CD was puri®ed on a GSH-sepharose column, cleaved with thrombin (Serva; 2 units/ml) in 32 mM Tris-HCl, pH 7.5+5 mM MgCl 2 +5 mM DTE+2 mM CaCl 2 followed by elution of C3G-CD in the same buer. The protein was concentrated by means of ultra®ltration (vivaspin). Aliquots were then snap-frozen in liquid nitrogen and stored at 7808C. The protein runs as a 30 kDa protein and was more than 80% pure as determined by SDSpolyacrylamide gelelectroforesis and Coomassie blue staining. Its identity was con®rmed by immunoblotting using C3G-speci®c antibodies (Santa Cruz). Thrombincleaved C3G-CD or GST-fused C3G-CD were used and gave similar results. Approximately 5 mg C3G-CD were obtained from a 10 liter E. coli culture.
Guanine nucleotide exchange reactions GTP-binding proteins, which are isolated as a mixture of GDP-or GTP-bound forms in various ratios, were loaded with the¯uorescent analogue mGDP. 2',3'-bis(O)-(Nmethylanthranoloyl)-guanosine-diphosphate, by incubating them in the presence of 10 mM EDTA and a 20-fold excess of mGDP for 4 ± 10 h at room temperature (Lenzen et al., 1995) . Protein-nucleotide complex was separated from unbound nucleotides by a small NAP5 prepacked gel ®ltration column (Pharmacia). Nucleotide content was assayed by HPLC (Lenzen et al., 1995) and related to the protein concentration determined by the Bradford assay (Bradford, 1976) . mGDP loading eciency usually was between 70 and 95%, except for Rap2A (30%). For the measurement of GEF activity, the protein-nucleotide complex was incubated at 258C in standard buer (50 mM Tris-HCl, pH 7.5, 5 mM DTE and 5 mM MgCl 2 ) with the indicated amount of GEF protein and a 100-fold excess of unlabeled GDP. The decrease of¯uorescence was monitored in a Perkin Elmer LS50¯uorescence spectrometer, with excitation and emission wavelengths of 366 and 450 nm, respectively. The K obs were obtained after ®tting the data to a single exponential function using the program Gra®t (Erithakus Software). For the apparent K M measurements, 50 mM C3G-CD was incubated with increasing concentrations of Rap1A . mGDP or Rap1A(S17N) . mGDP and the decrease of¯uorescence in the presence of a 200-fold excess of unlabeled GDP was measured with time. At Rap1A concentrations higher than 200 nM, the substrate was a mixture of 200 nM Rap1A . mGDP and increasing concentrations of Rap1A . GDP. The observed initial rates (pmol/s) were determined graphically and plotted against the concentration of substrate. The volume was 1200 ml.
Abbreviations m-GDP, 2',3'-bis(O)-(N-methylanthraniloyl)-guanosine-diphosphate; GST, gluthathione S-transferase.
